SHG · Healthcare

Sinotherapeutics Inc. A (688247)

Drug Manufacturers - Specialty & Generic

Sinotherapeutics Inc. A (688247) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $4.30B, P/E ratio is 45.14, net margin is 11.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 688247

Market cap
$4.30B
P/E ratio
45.14
Gross profit (TTM)
$446.50M
Net margin
11.0%

Sinotherapeutics Inc. A (688247) — FAQ

What is Sinotherapeutics Inc. A's market cap?

Sinotherapeutics Inc. A (688247) has a reported market cap of $4.30B (data as of 2026-03-29).

What is 688247's P/E ratio?

The price-to-earnings (P/E) ratio for Sinotherapeutics Inc. A (688247) is 45.14 (data as of 2026-03-29).

Does Sinotherapeutics Inc. A pay a dividend?

Dividend yield is not available in the current snapshot for Sinotherapeutics Inc. A (688247). Check the MyAverix Finance app for the latest dividend data.

What sector is Sinotherapeutics Inc. A in?

Sinotherapeutics Inc. A (688247) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 688247 listed on?

688247 is listed on SHG.

What is Sinotherapeutics Inc. A's net margin?

Sinotherapeutics Inc. A (688247) reports a net margin of 11.0% (data as of 2026-03-29).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play